Actinium Successfully Completes Second Module of Collaborative Research Program with Astellas; Third Module Initiated

NEW YORK, March 29, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) announced today that it has successfully completed the second module of its previously announced research and option agreement with Astellas Pharma Inc. and that the third module has been...

from PR Newswire: https://ift.tt/2JOv8CS